SCHEMBL3978466

SCHEMBL3978466

CCOC(=O)c1occ(-c2cccc(OCc3ccccc3)c2)c1-c1cccc(OCc2ccccc2)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 1/20 0.51
JAK2 O60674 1/20 0.49
JAK3 P52333 1/20 0.49
MAOB P27338 3/20 0.46
MEN1 O00255 1/20 0.45
HSP90AA1 P07900 1/20 0.45
KMT2A Q03164 1/20 0.45
MRGPRX4 Q96LA9 1/20 0.45
FFAR1 O14842 3/20 0.44
NR4A2 P43354 1/20 0.43
PTGER4 P35408 1/20 0.43
GABRA1 P14867 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
GABRA2 P47869 1/20 0.42
PIN1 Q13526 1/20 0.42
MAPT P10636 1/20 0.42
ERN1 O75460 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3982581 0.98 PPARG (0.51) PPARGJAK2JAK3MAOBMEN1
SCHEMBL3982596 0.98 PPARG (0.51) PPARGJAK2JAK3MAOBMEN1
SCHEMBL3976144 0.88 PPARG (0.50) PPARGJAK2JAK3MAOBMEN1
SCHEMBL3977508 0.88 JAK2 (0.48) PPARGJAK2JAK3MAOBMEN1
SCHEMBL3973638 0.87 FABP3 (0.43) PPARGJAK2JAK3FFAR1PTGER4
SCHEMBL3982728 0.87 MAPT (0.41) PPARGJAK2JAK3FFAR1PTGER4
SCHEMBL3980972 0.86 FFAR1 (0.40) PPARGJAK2JAK3FFAR1PTGER4
SCHEMBL3979344 0.83 SMPD1 (0.47) MAOBMRGPRX4NR4A2PIN1MAPT
SCHEMBL3973642 0.82 MAPT (0.46) MEN1KMT2AMAPT
SCHEMBL3981475 0.82 GAA (0.45) MEN1KMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7514452-B2 2-furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON PHARMACEUTICAL CO., LTD (JP) 2009-04-07 US disclosed
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2005-08-04 US disclosed
EP-1489077-A1 2-FURANCARBOXYLIC ACID HYDRAZIDES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 2004-12-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050171196-A1 2-Furancarboxylic acid hydrazides and pharmaceutical compositions containing the same GLP1R, GCGR, GPR119 PPARG 155/4885JAK2 2506/4885JAK3 4229/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.